circ_0004140 promotes LUAD tumor progression and immune resistance through circ_0004140/miR-1184/CCL22 axis
出版年份 2022 全文链接
标题
circ_0004140 promotes LUAD tumor progression and immune resistance through circ_0004140/miR-1184/CCL22 axis
作者
关键词
-
出版物
Cell Death Discovery
Volume 8, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-04-08
DOI
10.1038/s41420-022-00983-w
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Immune Resistance in Lung Adenocarcinoma
- (2021) Magda Spella et al. Cancers
- Radiation-enhanced expression of CCL22 in nasopharyngeal carcinoma is associated with CCR4+ CD8 T cell recruitment
- (2020) Hanghang Li et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis
- (2020) Xiao-Yong Huang et al. Molecular Cancer
- Systematic profiling of immune signatures identifies prognostic predictors in lung adenocarcinoma
- (2020) Shuangshuang Mao et al. CELLULAR ONCOLOGY
- CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain
- (2020) Joanna Bogacka et al. Frontiers in Immunology
- Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
- (2020) Mariacarmela Santarpia et al. Cancers
- Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
- (2020) Qingyang Lei et al. Frontiers in Cell and Developmental Biology
- Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma
- (2019) Dimitra Kerdidani et al. Nature Communications
- The circ RNA ‐micro RNA code: emerging implications for cancer diagnosis and treatment
- (2019) Lorena Verduci et al. Molecular Oncology
- CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes
- (2019) Moritz Rapp et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion
- (2019) Dong Wang et al. CANCER LETTERS
- Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR‐567/PTPRG regulatory pathway
- (2019) Chengtao Yu et al. CELL PROLIFERATION
- Epstein–Barr virus-positive pyothorax-associated lymphoma expresses CCL17 and CCL22 chemokines that attract CCR4-expressing regulatory T cells
- (2019) Tomonori Higuchi et al. CANCER LETTERS
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CircRNAs in cancer metabolism: a review
- (2019) Tao Yu et al. Journal of Hematology & Oncology
- The biogenesis, biology and characterization of circular RNAs
- (2019) Lasse S. Kristensen et al. NATURE REVIEWS GENETICS
- Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis
- (2019) Zheng-Lin Ou et al. RNA Biology
- Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell Lymphoma
- (2019) Kayo Tanita et al. Frontiers in Oncology
- CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1
- (2019) Jiayu Zhou et al. Cell Death & Disease
- Higher CCL22+ Cell Infiltration is Associated with Poor Prognosis in Cervical Cancer Patients
- (2019) Qun Wang et al. Cancers
- The emerging functions and roles of circular RNAs in cancer
- (2018) Shibin Qu et al. CANCER LETTERS
- Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
- (2018) Shetal A. Patel et al. IMMUNITY
- A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy
- (2018) Masahiro Shibata et al. INTERNATIONAL JOURNAL OF CANCER
- CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjögren's Syndrome
- (2018) Aya Ushio et al. Frontiers in Immunology
- ZKSCAN1gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways
- (2017) Zhicheng Yao et al. Molecular Oncology
- Circular RNAs in cancer: opportunities and challenges in the field
- (2017) L S Kristensen et al. ONCOGENE
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment
- (2016) Evelina Martinenaite et al. OncoImmunology
- Suppression of Intratumoral CCL22 by Type I Interferon Inhibits Migration of Regulatory T Cells and Blocks Cancer Progression
- (2015) David Anz et al. CANCER RESEARCH
- Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time
- (2015) Mi Zhou et al. INTERNATIONAL JOURNAL OF CANCER
- Cellular Mechanisms of CCL22-Mediated Attenuation of Autoimmune Diabetes
- (2015) Loraine Bischoff et al. JOURNAL OF IMMUNOLOGY
- Regulation of circRNA biogenesis
- (2015) Ling-Ling Chen et al. RNA Biology
- The role of the CCL22-CCR4 axis in the metastasis of gastric cancer cells into omental milky spots
- (2014) Liang Cao et al. Journal of Translational Medicine
- The multilayered complexity of ceRNA crosstalk and competition
- (2014) Yvonne Tay et al. NATURE
- Natural RNA circles function as efficient microRNA sponges
- (2013) Thomas B. Hansen et al. NATURE
- TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma
- (2012) Pengyuan Yang et al. CANCER CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now